Mustafa Deebajah MD

Clinical Instructor
Education & Training
Jordan University of Science and Technology - MD
Research Interests

Artificial intelligence application in anatomy and clinical pathology

Computational pathology

Prediction of disease outcome

Prostate pathology

Representative Publications
  1. Pokharel A, Anderson JD, Deebajah M, Blatt NB, Reddy G, Garlapaty V, Li W, Kanaan HD, Zhang PL. Podocytopathies related to either COVID-19 infection or its vaccination, our experience and literature review. Ultrastruct Pathol. 2023 Jul 18:1-9. doi: 10.1080/01913123.2023.2237565. Epub ahead of print. PMID: 37463165.
  2. ElKarami B, Deebajah M, Polk S, Peabody J, Shahrrava B, Menon M, Alkhateeb A, Alanee S. Machine learning-based prediction of upgrading on magnetic resonance imaging targeted biopsy in patients eligible for active surveillance. Urol Oncol. 2022 May;40(5):191.e15-191.e20. doi: 10.1016/j.urolonc.2022.01.012. Epub 2022 Mar 17. PMID: 35307289.
  3. Alanee S, Chammout D, Deebajah M, Peabody J, Menon M. Association of request for opioid medications refill after hospital discharge with race in patients with prostate cancer treated with robotic-assisted laparoscopic radical prostatectomy. J Opioid Manag. 2022 Sep-Oct;18(5):447-453. doi: 10.5055/jom.2022.0738. PMID: 36226784.
  4. Alanee S, Deebajah M, Dabaja A, Peabody J, Menon M. Utilizing lesion diameter and prostate specific antigen density to decide on magnetic resonance imaging guided confirmatory biopsy of prostate imaging reporting and data system score three lesions in African American prostate cancer patients managed with active surveillance. Int Urol Nephrol. 2022 Apr;54(4):799-803. doi: 10.1007/s11255-022-03136-1. Epub 2022 Feb 9. PMID: 35138582.
  5. Alhamar M, Jabbar A, Deebajah M, et al. Prognostic significance of histomorphologic features of lymph node metastases in prostate cancer patients treated with radical prostatectomy: A single center study [published online ahead of print, 2021 May 10]. UrolOncol. 2021;S1078-1439(21)00128-9. doi:10.1016/j.urolonc.2021.03.018
  6. Alanee S, Sana S, El-Zawahry A, Deebajah M, et al. Phase I trial of intravesical Bacillus Calmette-Guérin combined with intravenous pembrolizumab in recurrent or persistent high-grade non-muscle-invasive bladder cancer after previous Bacillus Calmette-Guérin treatment [published online ahead of print, 2021 May 8]. World J Urol. 2021;10.1007/s00345-021-03716-3. doi:10.1007/s00345-021-03716-3
  7. Alanee S, Deebajah M, Taneja K, et al. Post Prostatectomy Pathologic Findings of Patients With Clinically Significant Prostate Cancer and no Significant PI-RADS Lesions on Preoperative Magnetic Resonance Imaging. Urology. 2020;146:183-188. doi:10.1016/j.urology.2020.07.068
  8. Yaguchi G, Tang HJ, Deebajah M, et al. The effect of multiplicity of PI-RADS 3 lesions on cancer detection rate of confirmatory targeted biopsy in patients diagnosed with prostate cancer and managed with active surveillance. UrolOncol. 2020;38(6):599.e9-599.e13. doi:10.1016/j.urolonc.2020.03.002
  9. Jamil ML, Deebajah M, Sood A, Alanee S. Combination of pembrolizumab and BCG treatment after endoscopic ablation of high-risk superficial upper urinary tract urothelial carcinoma in patients not candidates for radical nephroureterectomy: protocol for phase-II study. BMJ Open. 2019;9(12):e027066. Published 2019 Dec 3. doi:10.1136/bmjopen-2018-027066
  10. Alanee S, Deebajah M, Chen PI, et al. Using adaptive genetic algorithms combined with high sensitivity single cell-based technology to detect bladder cancer in urine and provide a potential noninvasive marker for response to anti-PD1 immunotherapy. UrolOncol. 2020;38(3):77.e9-77.e15. doi:10.1016/j.urolonc.2019.08.019
  11. Arabi A, Deebajah M, Yaguchi G, et al. Systematic Biopsy Does Not Contribute to Disease Upgrading in Patients Undergoing Targeted Biopsy for PI-RADS 5 Lesions Identified on Magnetic Resonance Imaging in the Course of Active Surveillance for Prostate Cancer. Urology. 2019;134:168-172. doi:10.1016/j.urology.2019.08.035
  12. Jamil ML, Deebajah M, Sood A, et al. Protocol for phase I study of pembrolizumab in combination with Bacillus Calmette-Guérin for patients with high-risk non-muscle invasive bladder cancer. BMJ Open. 2019;9(7):e028287. Published 2019 Jul 17. doi:10.1136/bmjopen-2018-028287
  13. Deebajah M, Bazzi M, Walton E, et al. Prostate volume measured by magnetic resonance imaging is not a predictor of lower urinary tract symptoms. J Family Med Prim Care. 2019;8(4):1370-1373. doi:10.4103/jfmpc.jfmpc_94_19
  14. Walton EL, Deebajah M, Keeley J, et al. Barriers to obtaining prostate multi-parametric magnetic resonance imaging in African-American men on active surveillance for prostate cancer. Cancer Med. 2019;8(8):3659-3665. doi:10.1002/cam4.2149
  15. Deebajah M, Keeley J, Park H, et al. A propensity score matched analysis of the effects of African American race on the characteristics of regions of interests detected by magnetic resonance imaging of the prostate. UrolOncol. 2019;37(8):531.e1-531.e5. doi:10.1016/j.urolonc.2019.03.017
  16. Madan R, Deebajah M, Alanee S, et al. Prostate cancer with comedonecrosis is frequently, but not exclusively, intraductal carcinoma: a need for reappraisal of grading criteria. Histopathology. 2019;74(7):1081-1087. doi:10.1111/his.13833
  17. Walton E, Yaguchi G, Keeley J, Deebajah M, et al. Effect of Lesion Location on Prostate Cancer Detection Rate with Magnetic Resonance Imaging Targeted Biopsy in African Americans. J Urol. 2019;201(3):503-509. doi:10.1016/j.juro.2018.10.003
  18. Sood A, Cole D, Abdollah F, Deebajah M, et al. Endocrine, Sexual Function, and Infertility Side Effects of Immune Checkpoint Inhibitor Therapy for Genitourinary Cancers. CurrUrol Rep. 2018;19(9):68. Published 2018 Jul 3. doi:10.1007/s11934-018-0819-7